查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1883904

全球腸道疾病檢測市場

Enteric Disease Testing
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球腸道傳染病檢查市場規模將達31億美元。

2024年全球腸道傳染病檢查市場規模估計為23億美元，預計到2030年將達到31億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為4.9%。本報告分析的細分市場之一－細菌性腸道傳染病檢查，預計複合年成長率為4.8%，到分析期末將達到18億美元。寄生蟲性腸道傳染病檢查細分市場預計在分析期間內複合年成長率為4.1%。

美國市場規模估計為6.075億美元，而中國市場預計將以7.4%的複合年成長率成長。

預計到2024年，美國腸道傳染病檢查市場規模將達到6.075億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到6.765億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到7.4%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率將分別達到2.4%和4.5%。在歐洲，德國預計將以約2.7%的複合年成長率成長。

全球腸道傳染病檢查市場－主要趨勢與促進因素概述

腸道傳染病檢查如何改變公共衛生和疾病控制？

腸道傳染病檢查透過提供快速、準確和全面的診斷，徹底改變了公共衛生和疾病控制，有效診斷了影響胃腸道的感染疾病。由細菌、病毒和寄生蟲引起的腸道感染疾病是全球重要的健康問題，尤其是在清潔用水和衛生條件有限的地區。這些疾病會導致嚴重的脫水、營養不良，甚至死亡，尤其對兒童和老年人等弱勢族群危害更大。快速且準確地診斷腸道感染疾病對於有效治療、預防感染傳播和控制疫情至關重要。現代腸道傳染病檢查利用先進的診斷技術，包括分子檢測、免疫檢測和次世代定序，能夠以高靈敏度和特異性檢測多種病原體。透過幫助醫護人員快速確定胃腸道症狀的確切原因，腸道傳染病檢查能夠改善患者預後，減少感染傳播，並支持旨在控制和預防全球腸道感染疾病的公共衛生工作。

哪些創新將增強腸道傳染病檢查的功能？

分子診斷、就地檢驗和多重檢測平台技術的進步顯著提升了腸道傳染病檢查能力。其中一個最重要的進展是聚合酵素鏈鎖反應(PCR) 和其他核酸擴增技術的應用，這些技術能夠快速、高精度地檢測病原體的遺傳物質。與傳統培養方法需要數天時間相比，這些分子診斷方法可在數小時內識別糞便檢體中的特定細菌、病毒和寄生蟲。分子診斷的快速性和準確性對於控制集體爆發和迅速為患者提供適當治療尤為重要，從而降低併發症和感染傳播的風險。

即時檢測（POC​​T）是另一個改變腸道感染疾病診斷的重要創新。 POCT 設備專為在醫院床邊或偏遠地區使用而設計，無需專業實驗室設備即可提供即時結果。這些攜帶式、易於操作的設備在缺乏傳統檢測基礎設施的資源匱乏地區尤其重要。 POCT 能夠快速診斷和治療現場腸道感染疾病，縮短治療時間，並提高治療成功率。這項創新在疫情爆發情況下也至關重要，因為快速識別致病病原體可以阻止疾病傳播。

多重檢測平台是腸道傳染病檢查領域的另一個重大進展。這些系統能夠同時檢測單一檢體中的多種病原體，從而對胃腸道症狀的潛在病因進行全面分析。當症狀可能由多種病原體引起時，例如食源性疾病集體爆發或免疫力缺乏患者，多重檢測尤其有效。透過提供廣泛的診斷工具，多重檢測減少了多次單獨檢測的需求，從而能夠在節省時間和資源的同時，對患者的病情進行徹底的調查。

這些創新使得腸道傳染病檢查速度更快、更準確、更便捷，這對於有效控制疾病和保護公共衛生至關重要。

腸道傳染病檢查對公共衛生和病人預後有何影響？

腸道傳染病檢查對公共衛生和患者預後具有重要意義，它能夠及時診斷、治療和預防影響消化器官系統的感染疾病。對於每位患者而言，準確快速的檢測對於識別致病病原體和指導制定合適的治療策略至關重要。若未能做出正確診斷，患者可能接受無效或不恰當的治療，導致病程延長、併發症風險增加、醫療成本上升。腸道傳染病檢查能夠實現標靶治療，從而縮短病程、減輕病情，並最大限度地降低脫水等併發症的風險，尤其對兒童和老年人等弱勢群體意義重大。

從公共衛生角度來看，腸道傳染病檢查對於控制感染疾病的傳播至關重要。在社區集體爆發期間快速識別病原體，有助於公共衛生部門有效實施防控措施，例如隔離感染者、發佈公共警告以及追蹤污染源。對於食源性疾病，快速檢測可以識別受污染的食物，從而預防更多病例的發生，並保護公眾健康。此外，腸道傳染病檢查數據還有助於進行監測工作，例如追蹤疾病發生率趨勢、監測新出現的病原體以及評估公共衛生措施的有效性。

腸道傳染病檢查在全球衛生領域中發揮著至關重要的作用，尤其是在胃腸道感染疾病負擔沉重的地區。在清潔用水和衛生設施匱乏的地區，腸道感染疾病是導致發病率和死亡率的主要原因。透過提供早期發現和治療所需的工具，腸道傳染病檢查有助於減輕這些疾病的負擔，並支持更廣泛的改善弱勢群體健康的努力。此外，在難民營等人道環境中，快速且準確的檢測方法至關重要，因為腸道感染疾病疫情可能迅速蔓延並造成毀滅性後果。

整體而言，腸道傳染病檢查對公共衛生的影響是深遠的，它能改善患者的治療效果，加強疾病控制工作，並有助於預防未來的疫情爆發。

哪些趨勢正在推動腸道傳染病檢查市場的成長？

推動腸道傳染病檢查市場成長的關鍵趨勢包括食源性疾病發病率的上升、診斷技術的進步、對快速檢測解決方案日益成長的需求，以及旨在對抗感染疾病的全球公共衛生舉措。食源性疾病的日益增多是腸道傳染病檢查需求的主要促進因素。食品供應鏈的全球化程度不斷加深，導致受污染食品引發大規模疫情的風險增加，因此人們更加關注食品安全，也更加需要可靠的檢測方法來快速識別和控制此類疫情。

診斷技術的進步，尤其是分子診斷技術的進步，也推動了腸道傳染病檢查市場的成長。更快、更準確、更經濟的診斷工具的開發，擴大了腸道傳染病檢查的覆蓋範圍和可及性。諸如基於PCR的檢測、次世代定序和多重檢測平台等創新技術，即使在資源匱乏的環境下，也能以高靈敏度和特異性同時檢測多種病原體。這些進步不僅有助於改善患者照護，還能為監測和疫情應對提供所需數據，從而支持更廣泛的公共衛生工作。

對快速檢測解決方案日益成長的需求也是推動市場成長的關鍵趨勢。臨床和公共衛生領域對能夠快速提供檢測結果的診斷測試的需求日益成長，以便儘早進行治療和介入。在疫情爆發和自然災害等緊急情況下，這種需求尤其明顯，因為快速診斷對於預防感染疾病傳播和挽救生命至關重要。能夠現場快速準確檢測的就地檢驗設備的開發和應用正在滿足這一需求，並促進其在各種環境中的應用。

旨在減輕腸道感染負擔的全球公共衛生舉措，尤其是在中低收入國家，也推動了腸道傳染病檢查市場的成長。世界衛生組織（WHO）和美國疾病管制與預防中心（CDC）等機構正在投資旨在改善診斷可及性、加強疾病監測系統以及提高快速應對疫情能力的各項計畫。這些努力正在推動對能夠支持這些目標的先進腸道傳染病檢查解決方案的需求。

此外，對抗菌素抗藥性（AMR）的關注也影響腸道傳染病檢查市場。隨著人們對抗生素濫用和抗藥性病原體增加的擔憂日益加劇，準確診斷以確保適當治療變得愈發重要。能夠快速識別致病病原體及其抗藥性光譜的腸道傳染病檢查在對抗抗菌素抗藥性方面正變得至關重要。

這些趨勢凸顯了腸道傳染病檢查在改善公共衛生、加強疾病控制以及應對感染疾病挑戰方面的重要作用。隨著市場的不斷發展，檢測技術的創新和全球衛生舉措有望推動進一步的成長和發展，確保腸道傳染病檢查繼續成為全球醫療保健的重要組成部分。

部分：

檢測方法（常規檢測、分子診斷檢測、其他檢測方法）、疾病類型（細菌性腸道感染疾病、寄生蟲性腸道感染疾病、病毒性腸道感染疾病）

受訪公司範例

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia（CIDRZ）
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP11810

Global Enteric Disease Testing Market to Reach US$3.1 Billion by 2030

The global market for Enteric Disease Testing estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Parasitic Enteric Disease Testing segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$607.5 Million While China is Forecast to Grow at 7.4% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$607.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$676.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Enteric Disease Testing Market - Key Trends and Drivers Summarized

How Is Enteric Disease Testing Revolutionizing Public Health and Disease Management?

Enteric disease testing is revolutionizing public health and disease management by providing rapid, accurate, and comprehensive tools for diagnosing infections that affect the gastrointestinal tract. Enteric diseases, caused by bacteria, viruses, or parasites, are a significant global health concern, particularly in areas with limited access to clean water and sanitation. These diseases can lead to severe dehydration, malnutrition, and, in some cases, death, especially among vulnerable populations such as children and the elderly. The ability to quickly and accurately diagnose enteric infections is critical for effective treatment, containment, and prevention of outbreaks. Modern enteric disease testing leverages advanced diagnostic technologies, including molecular assays, immunoassays, and next-generation sequencing, to detect a wide range of pathogens with high sensitivity and specificity. By enabling healthcare providers to identify the exact cause of gastrointestinal symptoms promptly, enteric disease testing is improving patient outcomes, reducing the spread of infections, and supporting public health initiatives aimed at controlling and preventing enteric diseases worldwide.

What Innovations Are Enhancing the Functionality of Enteric Disease Testing?

Innovations in enteric disease testing are enhancing its functionality through advancements in molecular diagnostics, point-of-care testing, and multiplex testing platforms. One of the most significant developments is the use of polymerase chain reaction (PCR) and other nucleic acid amplification techniques, which allow for the rapid detection of genetic material from pathogens with high accuracy. These molecular diagnostic methods can identify specific bacteria, viruses, and parasites in stool samples within hours, compared to traditional culture methods that may take days. The speed and precision of molecular diagnostics are particularly valuable in managing outbreaks and ensuring that patients receive the appropriate treatment quickly, thereby reducing the risk of complications and transmission.

Point-of-care testing (POCT) is another key innovation that is transforming enteric disease diagnostics. POCT devices are designed for use at the bedside or in remote settings, providing immediate results without the need for specialized laboratory equipment. These portable, easy-to-use devices are particularly beneficial in resource-limited areas where access to traditional laboratory infrastructure may be lacking. POCT allows for the rapid diagnosis and treatment of enteric diseases in the field, reducing the time to care and improving the chances of a successful outcome. This innovation is also critical in outbreak situations, where timely identification of the causative pathogen can prevent the spread of disease.

Multiplex testing platforms represent another major advancement in enteric disease testing. These systems can simultaneously detect multiple pathogens from a single sample, providing a comprehensive analysis of potential causes of gastrointestinal symptoms. Multiplex tests are particularly useful in cases where symptoms could be caused by a variety of pathogens, such as in foodborne illness outbreaks or in immunocompromised patients. By providing a broad-spectrum diagnostic tool, multiplex testing reduces the need for multiple individual tests, saving time and resources while ensuring a thorough investigation of the patient’s condition.

These innovations are making enteric disease testing more rapid, accurate, and accessible, which is crucial for effective disease management and the protection of public health.

How Does Enteric Disease Testing Impact Public Health and Patient Outcomes?

Enteric disease testing has a profound impact on public health and patient outcomes by enabling the timely diagnosis, treatment, and prevention of infections that affect the gastrointestinal system. For individual patients, accurate and rapid testing is critical for identifying the specific pathogen responsible for their illness, which guides appropriate treatment. Without proper diagnosis, patients may receive ineffective or inappropriate treatments, leading to prolonged illness, increased risk of complications, and higher healthcare costs. Enteric disease testing allows for targeted therapy, reducing the duration and severity of the illness and minimizing the potential for complications such as dehydration, especially in vulnerable populations like children and the elderly.

From a public health perspective, enteric disease testing is essential for controlling the spread of infectious diseases. Rapid identification of pathogens in community outbreaks allows public health authorities to implement containment measures more effectively, such as isolating infected individuals, issuing public warnings, and tracing the source of contamination. In the case of foodborne illnesses, prompt testing can lead to the identification of contaminated food products, preventing further cases and protecting public health. Moreover, the data generated from enteric disease testing contribute to surveillance efforts, helping to track trends in disease incidence, monitor emerging pathogens, and evaluate the effectiveness of public health interventions.

Enteric disease testing also plays a vital role in global health, particularly in regions with high burdens of gastrointestinal infections. In areas where access to clean water and sanitation is limited, enteric diseases are a leading cause of morbidity and mortality. By providing the tools needed for early detection and treatment, enteric disease testing helps to reduce the burden of these diseases and supports broader efforts to improve health outcomes in vulnerable populations. Additionally, the availability of rapid and accurate testing is crucial in humanitarian settings, such as refugee camps, where outbreaks of enteric diseases can spread quickly and have devastating consequences.

Overall, the impact of enteric disease testing on public health is far-reaching, improving patient outcomes, enhancing disease control efforts, and contributing to the prevention of future outbreaks.

What Trends Are Driving Growth in the Enteric Disease Testing Market?

Several trends are driving growth in the enteric disease testing market, including the increasing incidence of foodborne illnesses, advancements in diagnostic technology, the rising demand for rapid testing solutions, and global public health initiatives aimed at controlling infectious diseases. The growing incidence of foodborne illnesses is a significant factor fueling the demand for enteric disease testing. As globalization of the food supply chain increases, the risk of widespread outbreaks caused by contaminated food products has risen, prompting greater emphasis on food safety and the need for reliable testing methods to quickly identify and contain such outbreaks.

Advancements in diagnostic technology, particularly in molecular diagnostics, are also contributing to the growth of the enteric disease testing market. The development of faster, more accurate, and cost-effective diagnostic tools has expanded the availability and accessibility of enteric disease testing. Innovations such as PCR-based assays, next-generation sequencing, and multiplex platforms have made it possible to detect multiple pathogens simultaneously with high sensitivity and specificity, even in low-resource settings. These advancements are not only improving patient care but also supporting broader public health efforts by providing essential data for surveillance and outbreak response.

The rising demand for rapid testing solutions is another key trend driving market growth. In both clinical and public health settings, there is a growing need for diagnostic tests that can deliver results quickly, allowing for prompt treatment and intervention. This demand is particularly acute in emergency situations, such as outbreaks or natural disasters, where timely diagnosis is critical to preventing the spread of disease and saving lives. The development and deployment of point-of-care testing devices that provide rapid, accurate results in the field are meeting this need and driving adoption in diverse settings.

Global public health initiatives aimed at reducing the burden of enteric diseases, particularly in low- and middle-income countries, are also driving growth in the enteric disease testing market. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are investing in programs to improve access to diagnostics, strengthen disease surveillance systems, and enhance the capacity for rapid response to outbreaks. These efforts are increasing the demand for advanced enteric disease testing solutions that can support these goals.

Additionally, the focus on antimicrobial resistance (AMR) is influencing the enteric disease testing market. With the growing concern over the misuse of antibiotics and the rise of resistant pathogens, there is an increasing emphasis on accurate diagnosis to ensure appropriate treatment. Enteric disease testing that can rapidly identify the causative pathogen and its resistance profile is becoming essential in the fight against AMR.

These trends highlight the critical role of enteric disease testing in improving public health, enhancing disease management, and responding to the challenges posed by infectious diseases. As the market continues to evolve, innovations in testing technology and global health initiatives will likely drive further growth and development, ensuring that enteric disease testing remains a vital component of healthcare worldwide.

SCOPE OF STUDY:

The report analyzes the Enteric Disease Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Testing Method (Conventional Testing, Molecular Diagnostic Testing, Other Testing Methods); Disease Indication (Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Enteric Disease Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Enteric Diseases Spurs Demand for Rapid Diagnostic Tests
    • Growing Travel and Migration Contributing to Spread of Enteric Pathogens
    • Integration of Point-of-Care Testing Devices in Remote and Resource-Limited Settings
    • Rising Healthcare Infrastructure Investments in Emerging Economies
    • Market Trends Towards Multiplexed Testing Platforms for Simultaneous Detection
    • Future Trends: AI and Machine Learning Integration in Diagnostic Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bacterial Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Viral Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Parasitic Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Molecular Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Enteric Disease Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • JAPAN
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • CHINA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • EUROPE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • GERMANY
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • INDIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030
  • AFRICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2015, 2025 & 2030

IV. COMPETITION